Aldeyra Therapeutics Inc. buy marge
Start price
28.09.18
/
50%
€12.09
Target price
30.07.19
€17.14
Performance (%)
-58.96%
End price
30.07.19
€4.96
Summary
This prediction ended on 30.07.19 with a price of €4.96. Massive losses of -58.96% were the result for the BUY prediction by marge. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aldeyra Therapeutics Inc. | 7.035% | 7.035% | -24.155% | -31.196% |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % | 60,42 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % | 87,82 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % | 66,93 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % | 60,46 % |
Comments by marge for this prediction
In the thread Aldeyra Therapeutics Inc. diskutieren
marge stimmt der Buy-Einschätzung von stratec zu
marge stimmt am 28.09.2018 der Buy-Einschätzung von stratec mit dem Kursziel 19$ zu.
Überschrift: Aldeyra multiple trials are set to read out in the second half of the year
(Vom Mitglied beendet)